3Ranta S, Zhang Y, Ross B, et al. The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8[J]. Nature Genet, 1999,2 (3) :233-236.
4Mitchell WA, Wheeler RB,Sharp JD, et al. Turkish variant late infantile neuronal ceroid lipofuscinosis (CLNT) may be allelic to CLN8[J]. Europ J Paediat Neurol,2001(Suppl A) :21-27.
5Ranta S, Topcu M, Tegelberg S, et al. Variant late infantile neuronal ceroid lipofuscinosis in a subset of Turkish patients is allelic to Northern epilepsy[J]. Hum Murat, 2004,23 (4)1300- 305.
6Nijssen PC, Brusse E, Leyten AC, et al. Autosomal dominant adult neuronal eeroid lipofuseinosis: parkinsonism dueto both striatal and nigral dysfunetion[J]. Mov Disord, 2002,17 (3) 482-487.
7Schulz A,Dhar S, Rylova S, et al. Impaired cell adhesion and apoptosis in a novel CLN9 Batten disease variant[J]. Ann Neurol, 2004,56 (3) : 342-350.
8Schulz A, Mousallem T, Venkataramani M, et al. The CLN9 protein, a regulator of dihydroceramide synthase[J]. J Biol Chem, 2006,281 (5) : 2784-2794.
10Caraballo R, Sologuestua A, Ruggieri VL, et al. Clinical and electroencephalographic aspects of late infantile neuronal ceroid lipofuscinosis[J].Rev Neurol,2005,40(3) :135-140.
二级参考文献17
1[1]Zeman W,Dyken P.Neuronal ceroid-lipofuscinosis(Batten's disease):relationship to a maurotic family idiocy? Pediatrics,1969,44:570～583
3[3]J Ezaki,I Tanida,N Kanehagi et al.A Lysosomal proteinase,the late infantile neuronal ceroid lipofuscinosis gene(CLN2)product,is essential for degradation of a hydrophobic protein,the subunit c of ATP synthase.J Neurochem,1999:72(6):2573～2582
4[4]Junji Ezaki,Mitsue Takeda-Ezaki,Masato Koike,et al.Characterization of Cln3p,the gene product responsible for juvenile neuronal ceroid lipofuscinosis,as a lysosomal integral membrane glycoprotein.J Neurochem,2003,87:1296～1308
5[5]Golabek AA,Kida E,Walus M,et al.CLN3 proteins regulates lysosomal pH and alters intracellular procssing of Alzheimer's amyloid-β protein precursor and cathepsin D in human cells.Mol Genet Metab,2000,70:203～213
6[6]Puranam KL,Guo WX,Qian WH,et al.CLN3 defines a novel antiapototic pathway operative in neurodegeneration and mediated by ceramide.Mol Genet Metab,1999,66:294～308
7[7]Juha Isosomppi,Jouni Vesa,Anu Jalanko,et al.Lysosomal localization of the neuronal ceroid lipofuscinosis CLN5 protein,Hum Mol Genet,2002,11:885～891
8[8]Claudia Heine,Bettina Koch,Stephan Storch,et al.Defective ER-resident membrane protein CLN6 Affects lysosomal degradation of endocytosed arylsulfatase A J Biol Chem,2004,10:1074
9[9]Liina Lonka,Aija Kyttala,Susanna Ranta,et al.The neuronal ceroid lipofuscinosis CLN8 membrane protein is a resident of the endoplasmic reticulum.Hum Mol Genet,2000,9:1691～1697
10[10]JM Weimer,E Kriscenski-Perry,Y Elshatory,et al.The neuronal ceroid lipofuscinoses:mutations in different proteins result in similar disese.Neuromolecular Med,2002,1(2):111～124
7Staretz-Chacham O,Lang TC,LaMarca ME,et al.Lysosomal storage disorders in newborn.Pediatrics,2009,123:1191-1207.
8Anderson G,Smith VV,Malone M,et al.Blood film examination for vacuolated lymphocytes in the diagnosis of metabolic disorders:retrospective experience of more 2500 cases from a single centre.J Clin Pathol,2005,58:1305-1310.
9Huang Y,Zhong N.Current status of diagnosis and treatment of lysosomal storage diseases in China.World J Pediatr,2006,2:245-251.
